IDH2 and neoplasm: IIDH1 and IDH2 are common mutated metabolic enzymes in cancer, and multiple studies have shown that they mutate in cancer, and mutant IDH can accelerate tumour progression, which indicates that mutant IDH is carcinogenic [89], [90], [91].